Physician profile
Nima M Adimi
NPI 1801186614
$114,021.48
in general payments reported to CMS, 2019-2025
13 companies · $46K in 2025
The $46K reported for 2025 was more than what 98% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $1,432 · 2021: $1,946 · 2022: $1,924 · 2023: $13K · 2024: $16K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Travel and Lodging: $20K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Consulting Fee: $10K · Food and Beverage: $5,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,180.00 |
| Travel and Lodging | $20,263.21 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,037.50 |
| Consulting Fee | $10,435.00 |
| Food and Beverage | $5,592.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $65,511.11 | 2019-2024 | Senza |
| Globus Medical, INC. | $45,957.95 | 2025 | Senza |
| Abbott Laboratories | $1,239.61 | 2019-2020 | |
| Medtronic, INC. | $494.48 | 2024-2025 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $271.81 | 2021-2024 | |
| Vertos Medical, INC. | $183.15 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $158.77 | 2023-2024 | Evoke, Evoke Scs |
| Si-Bone, INC. | $74.55 | 2022 | |
| Nalu Medical, INC. | $40.53 | 2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $29.43 | 2023-2025 | Sprint Pns System |
| Biotronik Nro, INC. | $27.74 | 2025 | Prospera |
| Medtronic USA, INC. | $20.36 | 2020 | |
| Vapotherm INC | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nima Adimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.